The BRCA1/2 variant frequency was low among the unselected BC patients, with 0.6% and 1.2% carrying a pathogenic or likely-pathogenic BRCA1 and BRCA2 variant, respectively. This evidence concerns the gene BRCA2 and breast cancer.